https://orcid.org/0000-0002-9706-9244
References
- Priya S, Singhvi G. Microneedles-based drug delivery strategies: a breakthrough approach for the management of pain. Biomed Pharmacother. 2022;155:113717. doi: 10.1016/j.biopha.2022.113717
- Gorantla S, Gorantla G, Saha RN, et al. CD44 receptor-targeted novel drug delivery strategies for rheumatoid arthritis therapy. Expert Opin Drug Deliv. 2021;18(11):1553–1557. doi: 10.1080/17425247.2021.1950686
- Ben Mrid R, Bouchmaa N, Ainani H, et al. Anti-rheumatoid drugs advancements: new insights into the molecular treatment of rheumatoid arthritis. Biomed Pharmacother. 2022;151:113126. doi: 10.1016/j.biopha.2022.113126
- Banji D, Banji OJF, Rashida S, et al. Bioavailability, anti-inflammatory and anti-arthritic effect of Acetyl keto boswellic acid and its combination with methotrexate in an arthritic animal model. J Ethnopharmacol. 2022;292:115200. doi: 10.1016/j.jep.2022.115200
- Wang H, Syrovets T, Kess D, et al. Targeting NF-κB with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. J Immunol. 2009;183(7):4755–4763. doi: 10.4049/jimmunol.0900521
- Chen Q Acetyl-11-keto- β -boswellic acid restrains inflammation and extracellular matrix degradation of osteoarthritis via suppression of NF- κ B pathway.
- Ding Q, Hu W, Wang R, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. 2023;8(1). doi: 10.1038/s41392-023-01331-9
- Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Neurol. 2014;4:1–10. doi: 10.3389/fphar.2013.00177
- Rahman M, Beg S, Verma A, et al. Phytoconstituents as pharmacotherapeutics in rheumatoid arthritis: challenges and scope of nano/submicromedicine in its effective delivery. J Pharm Pharmacol. 2017;69:1–14. doi: 10.1111/jphp.12661
- Majeed M, Nagabhushanam K, Lawrence L, et al. Boswellia serrata extract containing 30% 3-Acetyl-11-keto-boswellic acid attenuates inflammatory mediators and preserves extracellular matrix in collagen-induced arthritis. Front Physiol. 2021;12:12. doi: 10.3389/fphys.2021.735247
- Werz O. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. Planta Med. 2007;73(13):1331–1357. doi: 10.1055/s-2007-990242
- Goel A, Ahmad FJ, Singh RM, et al. Anti-inflammatory activity of nanogel formulation of 3-acetyl-11-keto- β-boswellic acid. Pharmacologyonline. 2009;3:311–318.
- Mehta M, Dureja H, Garg M. Development and optimization of boswellic acid-loaded proniosomal gel. Drug Deliv. 2016;23:3072–3081. doi: 10.3109/10717544.2016.1149744
- Goel A, Ahmad FJ, Singh RM, et al. 3-Acetyl-11-keto-β-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. J Pharm Pharmacol. 2010;62(2):273–278. doi: 10.1211/jpp.62.02.0016
- Badria F, Mazyed E. Formulation of Nanospanlastics as a promising approach for Improving the Topical delivery of a natural leukotriene inhibitor (3-Acetyl-11-keto-β-boswellic acid): statistical optimization, in vitro Characterization, and ex vivo permeation study. Drug Des Devel Ther. 2020;14:3697–3721. doi: 10.2147/DDDT.S265167